Skip to content

Clinical trials

Phase 1 Esophageal Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 1 Country / region: Japan Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062
20071
20081
20091
20141
20152
20161
20171
20191
20201
20212
20221
20231
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting6
Unknown status4
Active, not recruiting3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company5
Mie University2
Novartis Pharmaceuticals2
Pfizer2
AbbVie1
ImmunoFrontier, Inc.1
Japanese Foundation for Cancer Research1
Kinki University1
Ludwig Institute for Cancer Research1
Oncolys BioPharma Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms22
Ovarian Neoplasms9
Carcinoma, Non-Small-Cell Lung8
Stomach Neoplasms8
Colorectal Neoplasms7
Neoplasm Metastasis6
Triple Negative Breast Neoplasms6
Head and Neck Neoplasms5
Squamous Cell Carcinoma of Head and Neck5
Endometrial Neoplasms4

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.